Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page
- Check2 days agoChange DetectedThe history now includes a new revision entry v3.6.5, and the previous v3.6.4 entry was removed. This reflects a small metadata update to the page's revision history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new Revision: v3.6.4 is added to the history and the previous Revision: v3.6.3 is removed, indicating a recent site release update.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page history shows the latest revision updated to v3.6.3, replacing the previous v3.6.2. This reflects a minor update to the page's version rather than changes to study details.SummaryDifference0.1%

- Check45 days agoChange DetectedA new site revision entry v3.6.2 was added to the history, and the previous entry v3.6.0 was removed. This represents a minor background release update to the site rather than changes to the study data or public study information.SummaryDifference0.1%

- Check52 days agoChange DetectedA new 'Study Status' entry was added to the record history with associated date markers (2026-06-15 and 2026-06-11) and the value 50, while the existing entry from 2025-06-08 was deleted, updating the history timeline to reflect the latest status information.SummaryDifference0.2%

- Check59 days agoChange DetectedNew quick-access links for joining eligibility and contact information were added to the study record history page, and the site revision was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.